Gene: Kif4a (kinesin family member 4A) Rattus norvegicus
Analyze
Symbol:
Kif4a
Name:
kinesin family member 4A
RGD ID:
620526
Description:
Predicted to have ATP binding activity; microtubule binding activity; and microtubule motor activity. Predicted to be involved in mitotic cytokinesis and mitotic spindle midzone assembly. Predicted to localize to midbody and nucleoplasm. Orthologous to several human genes including KIF4A (kinesin family member 4A); INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 2-amino-2-deoxy-D-glucopyranose.
Type:
protein-coding
RefSeq Status:
MODEL
Also known as:
chromosome-associated kinesin KIF4A; Kif4; kinesin family member 4; kinesin heavy chain member 4
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
KIF4A (kinesin family member 4A) HGNC
Ensembl, HomoloGene, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Kif4 (kinesin family member 4) HGNC
Treefam, OrthoMCL, NCBI, OMA, HomoloGene, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Kif4a (kinesin family member 4A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
KIF4A (kinesin family member 4A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
KIF4A (kinesin family member 4A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Kif4a (kinesin family member 4A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
KIF4A (kinesin family member 4A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (African green monkey):
KIF4A (kinesin family member 4A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Kif4a (kinesin family member 4A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
KIF4B (kinesin family member 4B) HGNC
EggNOG, Inparanoid, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Alliance orthologs 3
Homo sapiens (human):
KIF4A (kinesin family member 4A)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|TreeFam)
Homo sapiens (human):
KIF4B (kinesin family member 4B)
Alliance
DIOPT (Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|TreeFam)
Mus musculus (house mouse):
Kif4 (kinesin family member 4)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|TreeFam)
Danio rerio (zebrafish):
kif4 (kinesin family member 4)
Alliance
DIOPT (PhylomeDB|TreeFam)
Caenorhabditis elegans (roundworm):
klp-19
Alliance
DIOPT (Ensembl Compara|InParanoid|OrthoInspector|PhylomeDB|TreeFam)
Drosophila melanogaster (fruit fly):
Klp3A
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoInspector|PANTHER|PhylomeDB)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 X 70,461,700 - 70,561,084 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl X 70,461,718 - 70,561,189 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 X 71,333,326 - 71,432,702 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 X 88,624,683 - 88,742,447 (+) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 X 88,780,760 - 88,785,576 (+) NCBI Celera X 66,080,644 - 66,182,985 (+) NCBI Celera Cytogenetic Map X q22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Imported Annotations - ClinVar
Agenesis of Corpus Callosum ISO RGD:1342700 8554872 ClinVar Annotator: match by term: Corpus callosum agenesis ClinVar autistic disorder ISO RGD:1342700 8554872 ClinVar Annotator: match by term: Autistic disorder of childhood onset ClinVar PMID:21681106 , PMID:30208311 epilepsy ISO RGD:1342700 8554872 ClinVar Annotator: match by term: Seizures ClinVar non-syndromic X-linked intellectual disability 100 ISO RGD:1342700 8554872 ClinVar Annotator: match by term: Mental retardation, X-linked 100 ClinVar obesity ISO RGD:1342700 8554872 ClinVar Annotator: match by term: Obesity ClinVar PMID:25741868 syndromic X-linked intellectual disability Lubs type ISO RGD:1342700 8554872 ClinVar Annotator: match by term: MECP2 duplication syndrome ClinVar PMID:25741868 visual epilepsy ISO RGD:1342700 8554872 ClinVar Annotator: match by term: Seizures ClinVar
Imported Annotations - CTD
hepatocellular carcinoma ISO RGD:1342700 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:28284560 Imported Annotations - OMIM
non-syndromic X-linked intellectual disability 100 ISO RGD:1342700 7240710 OMIM
(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1342700 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KIF4A mRNA CTD PMID:22079256 1,1-dichloroethene increases expression ISO RGD:1551183 6480464 vinylidene chloride results in increased expression of KIF4A mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1551183 6480464 1, 2-Dimethylhydrazine results in increased expression of KIF4 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1551183 6480464 Ethinyl Estradiol results in increased expression of KIF4 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1551183 6480464 Ethinyl Estradiol affects the expression of KIF4 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1551183 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF4 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1551183 6480464 Estradiol results in increased expression of KIF4A mRNA CTD PMID:25210133 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of KIF4A mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO RGD:1342700 6480464 Estradiol results in increased expression of KIF4A mRNA CTD PMID:16474171 17beta-estradiol multiple interactions ISO RGD:1551183 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of KIF4A mRNA] CTD PMID:25210133 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1551183 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1342700 6480464 2 more ... CTD PMID:31173147 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1551183 6480464 [2 more ... CTD PMID:25510870 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1551183 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551183 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF4 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KIF4A mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551183 6480464 Tetrachlorodibenzodioxin affects the expression of KIF4 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases phosphorylation EXP 6480464 Tetrachlorodibenzodioxin results in increased phosphorylation of KIF4A protein CTD PMID:23298284 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of KIF4A mRNA CTD PMID:17109745 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1342700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KIF4A mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:1551183 6480464 Fenretinide results in increased expression of KIF4A mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of KIF4A mRNA CTD PMID:24780913 acetohydrazide decreases expression ISO RGD:1551183 6480464 acetylhydrazine results in decreased expression of KIF4 mRNA CTD PMID:15282401 aflatoxin B1 affects expression ISO RGD:1342700 6480464 Aflatoxin B1 affects the expression of KIF4A protein CTD PMID:20106945 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of KIF4A mRNA CTD PMID:17109745 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of KIF4 mRNA CTD PMID:16483693 arsane affects methylation ISO RGD:1342700 6480464 Arsenic affects the methylation of KIF4A gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1342700 6480464 Arsenic affects the methylation of KIF4A gene CTD PMID:25304211 benzo[a]pyrene decreases expression ISO RGD:1342700 6480464 Benzo(a)pyrene results in decreased expression of KIF4A mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO RGD:1342700 6480464 Benzo(a)pyrene affects the methylation of KIF4A intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1342700 6480464 Benzo(a)pyrene results in increased methylation of KIF4A 5' UTR, Benzo(a)pyrene results in increased methylation of KIF4A promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1551183 6480464 Benzo(a)pyrene results in increased expression of KIF4 mRNA CTD PMID:32417428 benzo[a]pyrene decreases expression ISO RGD:1551183 6480464 Benzo(a)pyrene results in decreased expression of KIF4 mRNA CTD PMID:21569818 benzo[e]pyrene decreases methylation ISO RGD:1342700 6480464 benzo(e)pyrene results in decreased methylation of KIF4A intron CTD PMID:30157460 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of KIF4A mRNA CTD PMID:17109745 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KIF4 mRNA CTD PMID:18164116 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1342700 6480464 Mustard Gas results in decreased expression of KIF4A mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of KIF4 mRNA CTD PMID:20920545 bisphenol A increases expression ISO RGD:1342700 6480464 bisphenol A results in increased expression of KIF4A mRNA CTD PMID:16474171 bisphenol A decreases expression ISO RGD:1342700 6480464 bisphenol A results in decreased expression of KIF4A mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1342700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KIF4A mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KIF4A mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of KIF4A mRNA CTD PMID:26496021 bisphenol A decreases expression ISO RGD:1551183 6480464 bisphenol A results in decreased expression of KIF4 mRNA CTD PMID:26063408 cadmium atom decreases expression ISO RGD:1342700 6480464 Cadmium results in decreased expression of KIF4A mRNA CTD PMID:21120746 , PMID:24376830 calcitriol decreases expression ISO RGD:1342700 6480464 Calcitriol results in decreased expression of KIF4A mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1342700 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of KIF4A mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:1551183 6480464 Nanotubes, Carbon analog results in increased expression of KIF4 mRNA, Nanotubes, Carbon results in increased expression of KIF4 mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:1551183 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF4 mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1551183 6480464 chromium hexavalent ion affects the expression of KIF4 mRNA CTD PMID:28472532 cisplatin multiple interactions ISO RGD:1342700 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of KIF4A mRNA CTD PMID:21858171 cobalt dichloride decreases expression ISO RGD:1342700 6480464 cobaltous chloride results in decreased expression of KIF4A mRNA CTD PMID:19320972 , PMID:19376846 copper atom multiple interactions ISO RGD:1342700 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KIF4A mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1342700 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KIF4A mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1342700 6480464 Copper Sulfate results in decreased expression of KIF4A mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1342700 6480464 Cyclosporine results in decreased expression of KIF4A mRNA CTD PMID:20106945 more ... dexamethasone multiple interactions ISO RGD:1342700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KIF4A mRNA CTD PMID:28628672 dichloroacetic acid increases expression ISO RGD:1551183 6480464 Dichloroacetic Acid results in increased expression of KIF4 mRNA CTD PMID:28962523 disodium selenite decreases expression ISO RGD:1342700 6480464 Sodium Selenite results in decreased expression of KIF4A mRNA CTD PMID:18175754 doxorubicin affects response to substance ISO RGD:1342700 6480464 KIF4A protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO RGD:1342700 6480464 Doxorubicin results in decreased expression of KIF4A mRNA CTD PMID:30031762 enzyme inhibitor multiple interactions ISO RGD:1342700 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of KIF4A protein CTD PMID:23301498 folic acid multiple interactions ISO RGD:1551183 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF4 mRNA CTD PMID:20938992 folic acid multiple interactions ISO RGD:1342700 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of KIF4A mRNA CTD PMID:24657277 gamma-tocopherol increases expression ISO RGD:1551183 6480464 Tocopherols results in increased expression of KIF4 mRNA CTD PMID:17056531 genistein increases expression ISO RGD:1342700 6480464 Genistein results in increased expression of KIF4A mRNA CTD PMID:16474171 hydrazine decreases expression ISO RGD:1551183 6480464 hydrazine results in decreased expression of KIF4 mRNA CTD PMID:15282401 indometacin multiple interactions ISO RGD:1342700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KIF4A mRNA CTD PMID:28628672 isoflavones decreases expression ISO RGD:1342700 6480464 Isoflavones results in decreased expression of KIF4A mRNA CTD PMID:17374662 L-methionine multiple interactions ISO RGD:1551183 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF4 mRNA CTD PMID:20938992 lucanthone decreases expression ISO RGD:1342700 6480464 Lucanthone results in decreased expression of KIF4A mRNA CTD PMID:21148553 methapyrilene decreases methylation ISO RGD:1342700 6480464 Methapyrilene results in decreased methylation of KIF4A intron CTD PMID:30157460 methotrexate decreases expression ISO RGD:1342700 6480464 Methotrexate results in decreased expression of KIF4A mRNA CTD PMID:24657277 methotrexate multiple interactions ISO RGD:1342700 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of KIF4A mRNA CTD PMID:24657277 methylparaben decreases expression ISO RGD:1342700 6480464 methylparaben results in decreased expression of KIF4A mRNA CTD PMID:31745603 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:1551183 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of KIF4 mRNA CTD PMID:20061341 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1342700 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of KIF4A mRNA CTD PMID:24810058 N-nitrosodiethylamine increases expression ISO RGD:1551183 6480464 Diethylnitrosamine results in increased expression of KIF4 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KIF4 mRNA CTD PMID:18164116 N-nitrosodiethylamine multiple interactions ISO RGD:1551183 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of KIF4 mRNA] CTD PMID:17854601 N-Nitrosopyrrolidine decreases expression ISO RGD:1342700 6480464 N-Nitrosopyrrolidine results in decreased expression of KIF4A mRNA CTD PMID:32234424 omega-6 fatty acid increases expression ISO RGD:1342700 6480464 Fatty Acids, Omega-6 results in increased expression of KIF4A mRNA CTD PMID:16823509 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of KIF4 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KIF4 mRNA, [oxaliplatin co-treated with Topotecan] results in decreased expression of KIF4A mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:1551183 6480464 Ozone results in decreased expression of KIF4A mRNA CTD PMID:24336422 palbociclib decreases expression ISO RGD:1342700 6480464 palbociclib results in decreased expression of KIF4A mRNA CTD PMID:22869556 paracetamol increases expression ISO RGD:1342700 6480464 Acetaminophen results in increased expression of KIF4A mRNA CTD PMID:22230336 paracetamol decreases expression ISO RGD:1342700 6480464 Acetaminophen results in decreased expression of KIF4A mRNA CTD PMID:29067470 phenobarbital increases expression ISO RGD:1551183 6480464 Phenobarbital results in increased expression of KIF4 mRNA CTD PMID:20403969 phenobarbital affects expression ISO RGD:1551183 6480464 Phenobarbital affects the expression of KIF4 mRNA CTD PMID:23091169 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of KIF4 mRNA CTD PMID:19162173 pirinixic acid increases expression ISO RGD:1551183 6480464 pirinixic acid results in increased expression of KIF4 mRNA CTD PMID:23811191 pirinixic acid multiple interactions ISO RGD:1342700 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of KIF4A mRNA CTD PMID:19710929 piroxicam multiple interactions ISO RGD:1342700 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of KIF4A mRNA CTD PMID:21858171 potassium chromate multiple interactions ISO RGD:1342700 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KIF4A mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1342700 6480464 potassium chromate(VI) results in decreased expression of KIF4A mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1551183 6480464 Pregnenolone Carbonitrile results in increased expression of KIF4 mRNA CTD PMID:22698814 progesterone increases expression ISO RGD:1342700 6480464 Progesterone results in increased expression of KIF4A mRNA CTD PMID:18070364 progesterone decreases expression ISO RGD:1342700 6480464 Progesterone results in decreased expression of KIF4A mRNA CTD PMID:21795739 propanal decreases expression ISO RGD:1342700 6480464 propionaldehyde results in decreased expression of KIF4A mRNA CTD PMID:26079696 quercetin decreases expression ISO RGD:1342700 6480464 Quercetin results in decreased expression of KIF4A mRNA CTD PMID:21632981 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of KIF4A mRNA CTD PMID:28374803 silicon dioxide increases expression ISO RGD:1551183 6480464 Silicon Dioxide results in increased expression of KIF4 mRNA CTD PMID:29341224 sodium arsenite decreases expression ISO RGD:1551183 6480464 sodium arsenite results in decreased expression of KIF4 mRNA CTD PMID:30130555 sodium arsenite increases expression ISO RGD:1342700 6480464 sodium arsenite results in increased expression of KIF4A mRNA CTD PMID:29301061 sunitinib decreases expression ISO RGD:1342700 6480464 Sunitinib results in decreased expression of KIF4A mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1551183 6480464 Tamoxifen affects the expression of KIF4 mRNA CTD PMID:17555576 tert-butyl hydroperoxide increases expression ISO RGD:1551183 6480464 tert-Butylhydroperoxide results in increased expression of KIF4 mRNA CTD PMID:15003993 testosterone multiple interactions ISO RGD:1342700 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of KIF4A mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1342700 6480464 Testosterone results in decreased expression of KIF4A mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1551183 6480464 Carbon Tetrachloride affects the expression of KIF4 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1551183 6480464 Carbon Tetrachloride results in increased expression of KIF4 mRNA CTD PMID:31919559 thapsigargin decreases expression ISO RGD:1342700 6480464 Thapsigargin results in decreased expression of KIF4A mRNA CTD PMID:22378314 titanium dioxide increases expression ISO RGD:1551183 6480464 titanium dioxide results in increased expression of KIF4 mRNA CTD PMID:23557971 tocopherol increases expression ISO RGD:1551183 6480464 Tocopherols results in increased expression of KIF4 mRNA CTD PMID:17056531 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KIF4 mRNA, [oxaliplatin co-treated with Topotecan] results in decreased expression of KIF4A mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of KIF4A mRNA CTD PMID:25729387 triclosan decreases expression ISO RGD:1342700 6480464 Triclosan results in decreased expression of KIF4A mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1551183 6480464 trimellitic anhydride results in increased expression of KIF4 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1342700 6480464 troglitazone results in decreased expression of KIF4A mRNA CTD PMID:19140230 tungsten decreases expression ISO RGD:1551183 6480464 Tungsten results in decreased expression of KIF4 mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:1342700 6480464 Tunicamycin results in decreased expression of KIF4A mRNA CTD PMID:22378314 urethane increases expression ISO RGD:1342700 6480464 Urethane results in increased expression of KIF4A mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:1342700 6480464 Valproic Acid results in decreased methylation of KIF4A gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1342700 6480464 Valproic Acid results in decreased expression of KIF4A mRNA CTD PMID:28001369 vincaleukoblastine affects response to substance ISO RGD:1342700 6480464 KIF4A protein affects the susceptibility to Vinblastine CTD PMID:16217747 zoledronic acid decreases expression ISO RGD:1342700 6480464 zoledronic acid results in decreased expression of KIF4A mRNA CTD PMID:24714768
Gene-Chemical Interaction Annotations
